This study is for people with certain types of blood cancer, like acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). It looks at how well a screening tool works to match patients with the right treatment. Doctors will take samples of your bone marrow (a spongy tissue inside bones) and blood to check for special markers. These markers help doctors understand what is causing the cancer and how best to treat it. The study will help figure out if patients can join a special treatment trial or should continue with regular care. You might be asked to try different medicines or combinations of medicines to see what works best for your type of cancer.

Key Points:

• The study involves regular tests on your bone marrow and blood.
• Participation could involve different treatments depending on your cancer markers.
• There may be future visits and treatments if your condition changes.